SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 3rd, 2009 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • California
This Securities Purchase Agreement (this “Agreement”) is dated as of March 31, 2009, by and among Sunesis Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
WARRANT NO. CSW-___ NUMBER OF SHARES: ____________Sunesis Pharmaceuticals Inc • April 3rd, 2009 • Pharmaceutical preparations • California
This Certifies That, for value received, [____], or its permitted registered assigns (the “Holder”), is entitled to subscribe for and purchase at the Exercise Price (defined below) from Sunesis Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to [____] shares of the common stock of the Company, par value $0.0001 per share (the “Common Stock”). This warrant is one of a series of warrants issued by the Company as of the date hereof (individually, a “Warrant,” and collectively, the “Warrants”) pursuant to that certain Securities Purchase Agreement between the Company and each of the Purchasers that is a party thereto, dated as of March 31, 2009 (the “Purchase Agreement”).
INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • April 3rd, 2009 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations
This Investor Rights Agreement (this “Agreement”) is made and entered into as of April 3, 2009, by and among Sunesis Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the several investors signatory hereto (including any successor or assign of any investor signatory hereto, each an “Investor” and, collectively, the “Investors”).
